Clinical Trials Directory

Trials / Completed

CompletedNCT04517942

Evaluation of Peer-led EVERYbody Project

An Evaluation of the Peer-delivered EVERYbody Project: Eating Disorder Risk Factor Reduction for College Students

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
141 (actual)
Sponsor
Western Washington University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The second trial of the EVERYbody Project explored the efficacy of the inclusive body image intervention when delivered by college peer leaders. The peer-facilitated EVERYbody Project was compared to a video and expressive writing comparison intervention through one-month follow-up.

Detailed description

The initial trial of the EVERYbody Project established that professional leaders could deliver a universal, inclusive body image program for college students, with benefit above and beyond a waitlist control condition. The second trial of the EVERYbody Project aimed to further evaluate the intervention using a more disseminable facilitator model: trained college student peer leaders. It also utilized a more rigorous comparison condition, where peer leaders conducted the two-session EVERYbody Project program or a time-matched video and expressive writing intervention. College students within a university in the Pacific Northwest United States were invited to participate in programming (universal intervention target). Quantitative assessment included a comparison of changes in eating disorder risk factor outcomes across randomization conditions at pre- and post-intervention and one-month follow-up. Feasibility and acceptability explored the impact of the peer delivered program within universal college student audiences.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEVERYbody ProjectBrief behavioral intervention (4 hours across two meetings)
OTHERVideo + Expressive WritingBrief video-based intervention (4 hours across two meetings)

Timeline

Start date
2017-10-01
Primary completion
2018-09-01
Completion
2018-09-01
First posted
2020-08-19
Last updated
2021-08-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04517942. Inclusion in this directory is not an endorsement.